PRESS RELEASE
News
-
-
PRESS RELEASE
ISS Recommends The Swatch Group AG Shareholders Vote FOR GreenWood’s Director Nominee and Governance Proposals for the Company’s 2026 Annual Meeting of Shareholders
ISS recommends Swatch Group AG shareholders vote for GreenWood's director nominee and governance proposals for the 2026 Annual Meeting, emphasizing the need for governance change and independent oversight -
PRESS RELEASE
The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease
Study shows essential phospholipids significantly reduce liver fat and improve fatigue in Fatty Liver Disease patients with comorbidities like type 2 diabetes; EXCEL trial results published in Liver International -
-
-
PRESS RELEASE
Core Silver and Arcus Development Group Enter into a Binding Letter of Intent for a Business Combination Transaction and Sign a Definitive Option Agreement for the Touleary Project
Core Silver Corp. and Arcus Development Group Inc. announce a business combination transaction involving the acquisition of Arcus shares by Core Silver, forming a Resulting Issuer. Core Silver also has an option to acquire a 20% interest in Arcus' Touleary property. The Proposed Transaction is subject to regulatory and shareholder approvals -
PRESS RELEASE
Eagle Plains Announces Letter of Intent with Pacific Bay Minerals for the Haskins Critical Minerals Project, British Columbia
Eagle Plains Resources Ltd. enters non-binding LOI with Pacific Bay Minerals Corp. for Haskins Project acquisition. Project highly prospective for various mineralizations -
PRESS RELEASE
Inventus Announces Upsize of Non-Brokered Flow-Through Financing to $2.5 Million
Inventus Mining Corp. announces upsize to non-brokered flow-through private placement of common shares for gross proceed of up to $2.5 Million. Proceeds to accelerate exploration drilling at Pardo Gold Project -
-
PRESS RELEASE
CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026
Concept Medical presents preliminary 3-year SIRONA data at Charing Cross Symposium 2026, showcasing sirolimus-coated balloon's potential in peripheral interventions. High cdTLR reduction with MagicTouch PTA vs paclitaxel-coated balloon
